IBDEI1IM ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24528,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,24528,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,24529,0)
 ;;=I71.4^^85^1079^1
 ;;^UTILITY(U,$J,358.3,24529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24529,1,3,0)
 ;;=3^AAA w/o Rupture
 ;;^UTILITY(U,$J,358.3,24529,1,4,0)
 ;;=4^I71.4
 ;;^UTILITY(U,$J,358.3,24529,2)
 ;;=^5007789
 ;;^UTILITY(U,$J,358.3,24530,0)
 ;;=J30.9^^85^1079^9
 ;;^UTILITY(U,$J,358.3,24530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24530,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,24530,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,24530,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,24531,0)
 ;;=J45.909^^85^1079^18
 ;;^UTILITY(U,$J,358.3,24531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24531,1,3,0)
 ;;=3^Asthma Uncomplicated,Unspec
 ;;^UTILITY(U,$J,358.3,24531,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,24531,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,24532,0)
 ;;=M12.9^^85^1079^17
 ;;^UTILITY(U,$J,358.3,24532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24532,1,3,0)
 ;;=3^Arthropathy,Unspec
 ;;^UTILITY(U,$J,358.3,24532,1,4,0)
 ;;=4^M12.9
 ;;^UTILITY(U,$J,358.3,24532,2)
 ;;=^5010666
 ;;^UTILITY(U,$J,358.3,24533,0)
 ;;=T78.40XA^^85^1079^10
 ;;^UTILITY(U,$J,358.3,24533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24533,1,3,0)
 ;;=3^Allergy,Unspec Initial Encounter
 ;;^UTILITY(U,$J,358.3,24533,1,4,0)
 ;;=4^T78.40XA
 ;;^UTILITY(U,$J,358.3,24533,2)
 ;;=^5054284
 ;;^UTILITY(U,$J,358.3,24534,0)
 ;;=L40.2^^85^1079^5
 ;;^UTILITY(U,$J,358.3,24534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24534,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,24534,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,24534,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,24535,0)
 ;;=F10.10^^85^1079^7
 ;;^UTILITY(U,$J,358.3,24535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24535,1,3,0)
 ;;=3^Alcohol Abuse Uncomplicated
 ;;^UTILITY(U,$J,358.3,24535,1,4,0)
 ;;=4^F10.10
 ;;^UTILITY(U,$J,358.3,24535,2)
 ;;=^5003068
 ;;^UTILITY(U,$J,358.3,24536,0)
 ;;=F43.0^^85^1079^6
 ;;^UTILITY(U,$J,358.3,24536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24536,1,3,0)
 ;;=3^Acute Stress Reaction
 ;;^UTILITY(U,$J,358.3,24536,1,4,0)
 ;;=4^F43.0
 ;;^UTILITY(U,$J,358.3,24536,2)
 ;;=^5003569
 ;;^UTILITY(U,$J,358.3,24537,0)
 ;;=Z89.511^^85^1079^4
 ;;^UTILITY(U,$J,358.3,24537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24537,1,3,0)
 ;;=3^Acquired Absence Right Leg Below Knee
 ;;^UTILITY(U,$J,358.3,24537,1,4,0)
 ;;=4^Z89.511
 ;;^UTILITY(U,$J,358.3,24537,2)
 ;;=^5063566
 ;;^UTILITY(U,$J,358.3,24538,0)
 ;;=Z89.512^^85^1079^3
 ;;^UTILITY(U,$J,358.3,24538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24538,1,3,0)
 ;;=3^Acquired Absence Left Leg Below Knee
 ;;^UTILITY(U,$J,358.3,24538,1,4,0)
 ;;=4^Z89.512
 ;;^UTILITY(U,$J,358.3,24538,2)
 ;;=^5063567
 ;;^UTILITY(U,$J,358.3,24539,0)
 ;;=Z79.2^^85^1079^15
 ;;^UTILITY(U,$J,358.3,24539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24539,1,3,0)
 ;;=3^Antibiotics Long Term (Current) Use
 ;;^UTILITY(U,$J,358.3,24539,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,24539,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,24540,0)
 ;;=E53.8^^85^1080^1
 ;;^UTILITY(U,$J,358.3,24540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24540,1,3,0)
 ;;=3^B Vitamin Group Deficiency,Oth Specified
 ;;^UTILITY(U,$J,358.3,24540,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,24540,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,24541,0)
 ;;=F31.9^^85^1080^2
